Harness Dickey Harnessing Innovation for 100 Years
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • IP Atlas
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • Litigation

      ALL CATEGORIES

      • Biologics & Biosimilars
        • Antitrust Issues
        • Competitor Dynamics
        • FDA Guidance & Updates
        • Interchangeability
      • BioPharma
      • Chemistry & Nanotechnology
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Jewell N. BriggsJewell N. Briggs 8
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 1
    • William J. CoughlinWilliam J. Coughlin 1
    • Matthew L. CutlerMatthew L. Cutler 192
    • Donald J. DaleyDonald J. Daley 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Glenn E. ForbisGlenn E. Forbis 11
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Michael P. KellaMichael P. Kella 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 10
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 4
    • Kisuk LeeKisuk Lee 1
    • Chris K. MillerChris K. Miller 1
    • Michael R. NyeMichael R. Nye 4
    • Joshua A. PartingtonJoshua A. Partington 4
    • Leanne M. RakersLeanne M. Rakers 26
    • Douglas A. RobinsonDouglas A. Robinson 17
    • Joel R. SamuelsJoel R. Samuels 16
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 640
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3
  • Harness Dickey IP Lawyers

    April 6, 2021

    Copying for Compatability, Rather than Creativity, is Fair

    More

  • Eggs Shaped Patent Claim Descriptors

    April 2, 2021

    Easter Patents for Eggheads

    More

  • Photo of Shamrocks, a share seen in many U.S. Patents

    March 17, 2021

    Shamrock-shaped Patents

    More

  • Shamrocks and Patents for St. Patrick's Day

    March 17, 2021

    St. Patrick’s Day in Patent History

    More

  • Patent Litigation Lawsuit

    March 11, 2021

    Can you Patent Something that Doesn’t Work?

    More

  • Restaurant Baristas Wearing Uniforms Protectable by Trademarks

    March 11, 2021

    A Uniform Policy on Trademarks

    More

Harness Dickey IP Attorneys

March 8, 2021

Hindsight May be 20-20, but it has no Place in Evaluating Obviousness

By: Bryan K. Wheelock, Principal

Harness Dickey patent Attorneys Detroit St. Louis Dallas Washington, DC

January 6, 2021

Even If Phrase Was In the Preamble, it is a Claim Limitation that was Not Met

By: Bryan K. Wheelock, Principal

December 29, 2020

Late Request For Leave to Amend Complaint to try to Save Patent on Ineligible Subject Matter Denied

By: Bryan K. Wheelock, Principal

photo of chess pieces representing biosimilar competitive dynamics

December 7, 2020

Breach of Confidentiality Agreement Required Transfer for Resulting Patents

By: Bryan K. Wheelock, Principal

November 20, 2020

Apparatus Claims Sometimes Incorporate Process Limitations, but Not this Time

By: Bryan K. Wheelock, Principal

Harness Dickey IP Litigation PTAB Proceedings

August 28, 2020

Inventorship, Unlike a Claim, is a “Nose of Wax”

By: Bryan K. Wheelock, Principal

Harness Dickey IP Attorneys

August 27, 2020

Pointed Tip is Not a Substantially Flat Surface

By: Bryan K. Wheelock, Principal

August 27, 2020

Clear Claim Language Trumped Written Description in Construction

By: Bryan K. Wheelock, Principal

mage of cracked light bulb to denote IP legal dispute

August 27, 2020

Upper and Lower Claim Limitations Leave Patent Owner Feeling Down

By: Bryan K. Wheelock, Principal

Harness Dickey IP Law & The Constitution

August 21, 2020

Constitutional Rights: Use Them or Lose Them

By: Bryan K. Wheelock, Principal

Patent Litigation and Res Judicata

August 21, 2020

Local Rules, unlike the Pirate Rules, Are More than Mere Guidelines and Ignoring Them Can Cause a Loss of Rights

By: Bryan K. Wheelock, Principal

August 4, 2020

Reason for Claim Amendment Was Tangential to Equivalent, Doctrine of Equivalents Applies

By: Bryan K. Wheelock, Principal

August 1, 2020

Improved Method of Operating a Flow Cytometry Apparatus Is Not Abstract

By: Bryan K. Wheelock, Principal

Chemical Patents

August 1, 2020

“Half-Liquid” is Wholly Indefinite

By: Bryan K. Wheelock, Principal

Patent Litigation

August 1, 2020

Lack of Likelihood of Success and Irreparable Harm Doomed Preliminary Injunction

By: Bryan K. Wheelock, Principal

IP Litigation and Contested Matters

July 14, 2020

Licensee’s Failure to Mark Ruined Patent Owner’s Claim for $3.5 Million in Pre-Suit Damages

By: Bryan K. Wheelock, Principal

July 9, 2020

Board Should Fix Obvious Claim Errors in Order to Make a Decision on the Merits

By: Bryan K. Wheelock, Principal

July 9, 2020

Over-designation of Confidential Information Costs Plaintiff Protection

By: Bryan K. Wheelock, Principal

photo of biosimilar medications

July 6, 2020

42 U.S.C. § 262(l)(8) Simply Requires 180 Day Notice before Sale of a Biosimilar Product

By: Bryan K. Wheelock, Principal

July 6, 2020

Past History is as Relevant as Current Conduct in Attorneys’ Fee Award

By: Bryan K. Wheelock, Principal

Posts navigation

1 2 … 8 Load more posts

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2021 Harness, Dickey & Pierce, P.L.C. All rights reserved.